Top-Rated Stocks NASDAQ:JAZZ Jazz Pharmaceuticals - JAZZ Insider Trading & Ownership Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jazz Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. $146.33 +1.41 (+0.97%) (As of 03/31/2023 12:00 AM ET) Add Compare Share Share Today's Range$144.43▼$146.9650-Day Range$133.98▼$157.7752-Week Range$125.36▼$169.98Volume505,170 shsAverage Volume572,481 shsMarket Capitalization$9.27 billionP/E RatioN/ADividend YieldN/APrice Target$204.27 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Jazz Pharmaceuticals (NASDAQ:JAZZ) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.40%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)14Amount OfInsider Selling(Last 12 Months)$24.12 M JAZZ Insider Buying and Selling by Quarter Get JAZZ Insider Trade Alerts Want to know when executives and insiders are buying or selling Jazz Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Jazz Pharmaceuticals Insider Trades History Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails3/15/2023Patricia CarrCAOSell1,023$133.22$136,284.066,286 3/8/2023Kim SablichEVPSell3,013$139.74$421,036.6230,560 3/7/2023Kenneth W O'keefeDirectorSell2,690$138.39$372,269.1022,889 3/6/2023Finbar LarkinSVPSell1,706$143.92$245,527.5223,854 3/5/2023Patricia CarrCAOSell1,148$140.76$161,592.487,309 2/1/2023Bruce C CozaddCEOSell1,000$155.79$155,790.00367,078 1/3/2023Bruce C CozaddCEOSell3,000$159.86$479,580.00368,078 1/3/2023Samantha PearceSVPSell531$159.59$84,742.2911,309 12/21/2022Renee D GalaCFOSell2,635$160.00$421,600.0032,558 12/13/2022Samantha PearceSVPSell531$155.45$82,543.9511,309 12/9/2022Robert IannoneEVPSell1,844$151.54$279,439.7636,316 12/5/2022Patricia CarrCAOSell63$152.06$9,579.785,934 12/2/2022Jennifer E CookDirectorSell420$154.68$64,965.605,471 12/1/2022Bruce C CozaddCEOSell1,000$157.00$157,000.00371,078 11/22/2022Patrick G EnrightDirectorSell4,974$149.48$743,513.5219,112 11/14/2022Finbar LarkinSVPSell197$149.33$29,418.0119,409 11/10/2022Bruce C CozaddCEOSell2,000$150.00$300,000.00372,028 11/10/2022Samantha PearceSVPSell1,063$155.00$164,765.0011,309 10/3/2022Bruce C CozaddCEOSell45,185$134.93$6,096,812.05374,028 9/7/2022Finbar LarkinSVPSell63$150.00$9,450.0019,606 9/6/2022Bruce C CozaddCEOSell7,703$153.18$1,179,945.54353,311 8/18/2022Peter GrayDirectorSell8,000$158.00$1,264,000.0014,234 8/15/2022Patricia CarrCAOSell2,142$160.06$342,848.525,934 8/4/2022Samantha PearceSVPSell531$155.00$82,305.0011,309 8/1/2022Bruce C CozaddCEOSell7,301$154.31$1,126,617.31354,311 7/12/2022Samantha PearceSVPSell532$155.00$82,460.0011,309 7/5/2022Bruce C CozaddCEOSell8,775$157.28$1,380,132.00351,912 7/5/2022Christopher J ToveyCOOSell5,209$160.00$833,440.0014,663 6/27/2022Samantha PearceSVPSell8,508$155.00$1,318,740.0011,309 6/8/2022Samantha PearceSVPSell8,487$155.00$1,315,485.0011,309 6/6/2022Kim SablichEVPSell1,388$152.15$211,184.2027,195 6/6/2022Neena M PatilInsiderSell1,000$152.15$152,150.0031,600 6/1/2022Bruce C CozaddCEOSell6,362$146.87$934,386.94351,987 5/11/2022Patricia CarrCAOSell722$147.51$106,502.226,234 5/9/2022Anne OriordanDirectorSell466$148.95$69,410.709,245 5/9/2022Finbar LarkinSVPSell1,747$148.94$260,198.1819,462 5/9/2022Patricia CarrCAOSell1,067$148.94$158,918.987,229 5/6/2022Neena M PatilInsiderSell296$153.92$45,560.3232,677 5/2/2022Bruce C CozaddCEOSell7,260$156.63$1,137,133.80348,502 4/4/2022Bruce C CozaddCEOSell10,772$158.33$1,705,530.76346,062 (Data available from 1/1/2013 forward) JAZZ Insider Trading Activity - Frequently Asked Questions Who is on Jazz Pharmaceuticals's Insider Roster? The list of insiders at Jazz Pharmaceuticals includes Anne Oriordan, Bruce C Cozadd, Christopher J Tovey, Elmar Schnee, Finbar Larkin, Jennifer E Cook, Kenneth W O'keefe, Kim Sablich, Mark Douglas Smith, Neena M Patil, Patricia Carr, Patrick G Enright, Paul L Berns, Peter Gray, Renee D Gala, Robert Iannone, Samantha Pearce, and Seamus Mulligan. Learn more on insiders at JAZZ. What percentage of Jazz Pharmaceuticals stock is owned by insiders? 4.40% of Jazz Pharmaceuticals stock is owned by insiders. Learn more on JAZZ's insider holdings. Which Jazz Pharmaceuticals insiders have been selling company stock? The following insiders have sold JAZZ shares in the last 24 months: Anne Oriordan ($69,410.70), Bruce C Cozadd ($18,736,939.90), Christopher J Tovey ($833,440.00), Elmar Schnee ($251,328.00), Finbar Larkin ($579,818.47), Jennifer E Cook ($64,965.60), Kenneth W O'keefe ($372,269.10), Kim Sablich ($1,003,228.30), Mark Douglas Smith ($50,582.10), Neena M Patil ($197,710.32), Patricia Carr ($938,955.76), Patrick G Enright ($743,513.52), Peter Gray ($1,264,000.00), Renee D Gala ($421,600.00), Robert Iannone ($279,439.76), and Samantha Pearce ($3,131,041.24). How much insider selling is happening at Jazz Pharmaceuticals? Insiders have sold a total of 208,442 Jazz Pharmaceuticals shares in the last 24 months for a total of $30,898,512.27 sold. This page (NASDAQ:JAZZ) was last updated on 4/2/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.